I agree that this site is using cookies. You can find further informations here.
X
Borg, Christophe
552  results:
?
1

Atezolizumab plus modified docetaxel, cisplatin, and fluoro..:

Kim, Stefano ; Ghiringhelli, Francois ; de la Fouchardière, Christelle...
The Lancet Oncology.  25 (2024)  4 - p. 518-528 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Trifluridine/tipiracil + oxaliplatin ± nivolumab vs FOLFOX ..:

Botsen, Damien ; Chabaud, Sylvie ; Perrier, Hervé...
Digestive and Liver Disease.  56 (2024)  8 - p. 1281-1287 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Visceral fat and clinical outcome in patients receiving fir..:

Cazeneuve, Nicolas ; Bouché, Olivier ; Leger, Julie...
Clinics and Research in Hepatology and Gastroenterology.  48 (2024)  7 - p. 102380 , 2024
Link: https://doi.org/10.1016/..
 
?
4

A comparison of target volumes drawn on arterial and venous..:

Zaidi, Fabien ; Calame, Paul ; Chevalier, Cédric...
Radiation Oncology.  19 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
5

Temporal and spatial heterogeneity of HER2 status in metast..:

D'Angelo, Flavia ; Monnien, Franck ; Overs, Alexis...
Diagnostic Pathology.  19 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
6

Prognostic Factors for Long-Term Eribulin Response in a Coh..:

El Kaddissi, Antoine ; Vernerey, Dewi ; Falcoz, Antoine...
Clinical Breast Cancer.  , 2024
Link: https://doi.org/10.1016/..
 
?
7

Prognostic value of the tumor-to-liver density ratio in pat..:

Mazard, Thibault ; Mollevi, Caroline ; Loyer, Evelyne M....
Cancer Imaging.  24 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
8

Evaluation of immune infiltrate according to the HER2 statu..:

Molimard, Chloé ; Dor, Fanny ; Overs, Alexis...
Digestive and Liver Disease.  56 (2024)  5 - p. 853-860 , 2024
Link: https://doi.org/10.1016/..
 
?
9

Efficacy and safety of maintenance therapy with pamiparib v..:

Ciardiello, Fortunato ; Bang, Yung‐Jue ; Cervantes, Andrés...
Cancer Medicine.  12 (2023)  12 - p. 13145-13154 , 2023
Link: https://doi.org/10.1002/..
 
?
10

SALL4‐related gene signature defines a specific stromal sub..:

Vienot, Angélique ; Monnien, Franck ; Truntzer, Caroline...
Molecular Oncology.  17 (2023)  7 - p. 1356-1378 , 2023
Link: https://doi.org/10.1002/..
 
?
11

Evaluation of the interest to combine a CD4 Th1-inducer can..:

Vienot, Angélique ; Jacquin, Marion ; Rebucci-Peixoto, Magali...
BMC Cancer.  23 (2023)  1 - p. , 2023
Link: https://doi.org/10.1186/..
 
?
12

Tucatinib plus trastuzumab for chemotherapy-refractory, HER..:

Strickler, John H ; Cercek, Andrea ; Siena, Salvatore...
The Lancet Oncology.  24 (2023)  5 - p. 496-508 , 2023
Link: https://doi.org/10.1016/..
 
?
13

Time to recurrence and its relation to survival after recur..:

Rasola, Cosimo ; Laurent-Puig, Pierre ; André, Thierry...
European Journal of Cancer.  194 (2023)  - p. 113321 , 2023
Link: https://doi.org/10.1016/..
 
?
14

CD8+ CD226high T cells in liver metastases dictate the prog..:

Viot, Julien ; Abdeljaoued, Syrine ; Vienot, Angélique...
Cellular & Molecular Immunology.  20 (2023)  4 - p. 365-378 , 2023
Link: https://doi.org/10.1038/..
 
?
15

CD3-CD8 immune score associated with a clinical score strat..:

Schoumacher, Coralie ; Derangère, Valentin ; Gaudillière-Le Dain, Gwladys...
OncoImmunology.  13 (2023)  1 - p. , 2023
Link: https://doi.org/10.1080/..
 
1-15